Angiotensin converting enzyme inhibitors or angiotensin receptor blockers: evidence for their effects on mortality and major cardiovascular events in hypertensive diabetics. Rev Port Med Geral Fam. 2016;32(5):330-38. doi:10.32385/rpmgf.v32i5.11887